Deep Track Capital LP 13D and 13G filings for Ambrx Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 10:19 am Sale | 2024-09-30 | 13G | Ambrx Biopharma Inc. AMAM | Deep Track Capital LP | 0 0.000% | -3,710,412 (Position Closed) | Filing |
| 2024-02-14 11:31 am Unchanged | 2023-12-31 | 13G | Ambrx Biopharma Inc. AMAM | Deep Track Capital LP | 3,710,412 5.880% | 0 (Unchanged) | Filing |
| 2023-11-02 4:09 pm Purchase | 2023-10-23 | 13G | Ambrx Biopharma Inc. AMAM | Deep Track Capital LP | 3,710,412 5.650% | 3,710,412 (New Position) | Filing |